Dopamine-1 Receptor Agonist: Renal Effects and Its Potential Role in the Management of Radiocontrast-Induced Nephropathy
Authors:
- 1 December 2004
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 44 (12) , 1342-1351
Abstract
Radiocontrast‐induced nephropathy remains the third leading cause of hospital‐acquired acute renal failure. Once established, this syndrome is associated with increased morbidity and mortality as well as increased health care costs. Recently, studies have been initiated to evaluate the potential of a selective dopamine‐1 receptor agonist (fenoldopam) in ameliorating radiocontrast‐induced renal failure. Selective dopamine‐1 receptor agonists exhibit many desirable renal effects that support their use for the prophylaxis of radiocontrast‐induced nephropathy, including decreases in renal vascular resistance and increases in renal blood flow, glomerular filtration, and sodium and water excretion. Several reports have documented a beneficial effect of fenoldopam administration in attenuating radiocontrast‐induced nephropathy. In contrast, a recent multicenter, randomized study did not demonstrate a renoprotective effect of fenoldopam against radiocontrast‐induced nephropathy. The presence of multiple confounders, however, precludes a definitive conclusion regarding the ability of fenoldopam to protect against radiocontrast‐induced nephropathy. Additional studies are needed to properly evaluate the role of fenoldopam in radiocontrast‐induced nephropathy prophylaxis.Keywords
This publication has 53 references indexed in Scilit:
- N-Acetylcysteine in the Prevention of Radiocontrast-Induced Nephropathy: Clinical Trials and End PointsKidney and Blood Pressure Research, 2004
- The Prevention of Radiocontrast-Agent–Induced Nephropathy by HemofiltrationNew England Journal of Medicine, 2003
- Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopamThe American Journal of Cardiology, 2002
- Pathophysiology of Radiocontrast NephropathyInvestigative Radiology, 1999
- Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptorsKidney International, 1999
- Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1994
- Contrast agents for cardiac catheterization: Conceptions and misconceptionsAmerican Heart Journal, 1991
- Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1991
- Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.Hypertension, 1990
- Diuresis and natriuresis during continuous dopamine-1 receptor stimulation.Hypertension, 1988